Clinical trials for

Primary Iga Nephropathy

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-generated · Refreshed daily · Not medical advice.

RecruitingObservational

Shanghai, Shanghai Municipality, ChinaCheck eligibility →

RecruitingSafety & dosing

Los Angeles, California, United States +4 moreCheck eligibility →

RecruitingEarly testing / Safety & dosing

Miami, Florida, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingInterventional

Saint Petersburg, Russia +1 moreCheck eligibility →

RecruitingSafety & dosing

Beijing, Beijing Municipality, China +1 moreCheck eligibility →

RecruitingPost-approval study

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Alabaster, Alabama, United States +4 moreCheck eligibility →

RecruitingObservational

Bristol, South West, United KingdomCheck eligibility →

RecruitingLarge-scale testing

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingObservational

Chengdu, Sichuan, ChinaCheck eligibility →

RecruitingLarge-scale testing

Palo Alto, California, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Glendale, Arizona, United States +4 moreCheck eligibility →

RecruitingSafety & dosing

Brisbane, California, United StatesCheck eligibility →

RecruitingObservational

Paris, FranceCheck eligibility →

RecruitingSafety & dosing

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingLarge-scale testing

Denver, Colorado, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Aurora, Colorado, United States +4 moreCheck eligibility →

RecruitingPost-approval study

Nadiād, Gujarat, India +4 moreCheck eligibility →

AI-generated · Refreshed daily · Not medical advice.

RecruitingObservational

Shanghai, Shanghai Municipality, ChinaCheck eligibility →

RecruitingSafety & dosing

Los Angeles, California, United States +4 moreCheck eligibility →

RecruitingEarly testing / Safety & dosing

Miami, Florida, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingInterventional

Saint Petersburg, Russia +1 moreCheck eligibility →

RecruitingSafety & dosing

Beijing, Beijing Municipality, China +1 moreCheck eligibility →

RecruitingPost-approval study

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Alabaster, Alabama, United States +4 moreCheck eligibility →

RecruitingObservational

Bristol, South West, United KingdomCheck eligibility →

RecruitingLarge-scale testing

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingObservational

Chengdu, Sichuan, ChinaCheck eligibility →

RecruitingLarge-scale testing

Palo Alto, California, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Glendale, Arizona, United States +4 moreCheck eligibility →

RecruitingSafety & dosing

Brisbane, California, United StatesCheck eligibility →

RecruitingObservational

Paris, FranceCheck eligibility →

RecruitingSafety & dosing

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingLarge-scale testing

Denver, Colorado, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Aurora, Colorado, United States +4 moreCheck eligibility →

RecruitingPost-approval study

Nadiād, Gujarat, India +4 moreCheck eligibility →

20 trials · Recruiting

20

Trials actively recruiting patients for Primary Iga Nephropathy

Trial status

Phase

Location